Home8AT • FRA
add
Aclaris Therapeutics Inc
Previous close
€3.69
Day range
€3.63 - €3.87
Year range
€0.81 - €4.52
Market cap
268.23M USD
Avg Volume
2.20K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 4.35M | -53.18% |
Operating expense | 10.48M | -62.41% |
Net income | -7.59M | 74.07% |
Net profit margin | -174.55 | 44.63% |
Earnings per share | -0.11 | 73.17% |
EBITDA | -9.59M | 67.77% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 127.72M | 23.94% |
Total assets | 182.39M | -16.47% |
Total liabilities | 52.24M | -15.77% |
Total equity | 130.15M | — |
Shares outstanding | 71.43M | — |
Price to book | 2.02 | — |
Return on assets | -14.08% | — |
Return on capital | -17.97% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -7.59M | 74.07% |
Cash from operations | 22.00M | 189.59% |
Cash from investing | 2.80M | -91.41% |
Cash from financing | 22.00K | 125.29% |
Net change in cash | 24.82M | 214.54% |
Free cash flow | 2.66M | 117.93% |
About
Founded
2012
Website
Employees
89
